Ideal Scientific Industries’ fiscal year 2026 results show net sales of \u00a57.99 billion (up 0.3% YoY), operating income of \u00a5511 million (down 17.3%), and net income attributable to shareholders of \u00a5437 million (up 7.1%). Segment-wise, the printing equipment-related business recorded sales of \u00a577.3 billion and profit of \u00a54.8 billion. Although overseas sales increased, sales in Japan declined, balancing out overall performance. Dividends are planned to continue at \u00a550 per share.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6413","jir_company_name":"Ideal Scientific Industries, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/6413-20260508-01.pdf","jir_short_summary":"Ideal Scientific Industries' fiscal year 2026 results show net sales of \u00a57.99 billion (up 0.3% YoY), operating income of \u00a5511 million (down 17.3%), and net income attributable to shareholders of \u00a5437 million (up 7.1%). Segment-wise, the printing equipment-related business recorded sales of \u00a577.3 billion and profit of \u00a54.8 billion. Although overseas sales increased, sales in Japan declined, balancing out overall performance. Dividends are planned to continue at \u00a550 per share.","jir_summary":"### Performance Summary\nIdeal Scientific Industries' fiscal year 2026 results show net sales of \u00a57.99 billion (up 0.3% YoY), remaining flat overall, while operating income declined by 17.3% to \u00a5511 million. Net income attributable to shareholders increased by 7.1% to \u00a5437 million. The segment primarily focuses on the printing equipment-related business, maintaining steady performance due to increased overseas sales, despite decreased sales in Japan's stencil business and global main units. The results also reflect currency exchange effects and business integrations.\n\n### Outlook and Impact on Shareholders\nThe next fiscal year's earnings forecast anticipates net sales of \u00a580.9 billion and net income of \u00a54.1 billion, assuming exchange rates of 1 USD = 150 JPY and 1 EUR = 175 JPY. Dividends are expected to remain at \u00a550 per share, with share buybacks already completed. The company aims for stable and growing operations while carefully monitoring geopolitical conditions in the Middle East and rising raw material costs.","jir_financial_highlights":"Net Sales: \u00a57.99 billion (YoY +0.3%)\nOperating Income: \u00a5511 million (YoY -17.3%)\nNet Income Attributable to Owners of Parent: \u00a5437 million (YoY +7.1%)","jir_category":"","jir_hashtags":"#IdealScientificIndustries, #IRFinancialResults, #JapanStocks","jir_key_figures":"Net Sales: \u00a57.99 billion (YoY +0.3%)\nOperating Income: \u00a5511 million (YoY -17.3%)\nNet Income Attributable to Owners of Parent: \u00a5437 million (YoY +7.1%)","jir_meta_title":"\u3010Ideal Scientific Industries\u30112026 Financial Results | \u00a57.99 billion in Sales (+0.3%)","jir_meta_description":"Ideal Scientific Industries' fiscal year 2026 results show net sales of \u00a57.99 billion and net income of \u00a5437 million. Detailed business overview and outlook included.","jir_og_title":"\u3010Ideal Scientific Industries\u30112026 Financial Results | \u00a57.99 billion in Sales (+0.3%)","jir_og_description":"Detailed overview of Ideal Scientific Industries' 2026 financial results and future prospects. Valuable information for investment decisions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16706,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-46217","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n